Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
ABSTRACT Mycobacterium abscessus infections are increasing worldwide necessitating the development of new antibiotics and treatment regimens. The utility of third-generation tetracycline antibiotics was reestablished; their anti-M. abscessus activity needs further study. The activities of omadacycli...
Main Authors: | Anqi Li, Siyuan He, Jingren Li, Zhemin Zhang, Bing Li, Haiqing Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-06-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00718-23 |
Similar Items
-
AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis
by: Yi-Tzu Lee, et al.
Published: (2020-11-01) -
In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
by: Tingting Zhang, et al.
Published: (2023-02-01) -
In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
by: Weiliang Zeng, et al.
Published: (2022-11-01) -
Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
by: Ayesha Siddiqa, et al.
Published: (2023-01-01) -
Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance
by: Kerry L. LaPlante, et al.
Published: (2022-12-01)